Using an ER-/PR- breast cancer cell line, Brown et al. [136] isolated three hybrid EMT clones and demonstrated that these intermediate clones had higher tumor-initiating capacity than fully mesenchymal phenotypes. This evidence concerns the gene PGR and breast carcinoma.